Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on June 7th, 2023%
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds
By Alan, on May 24th, 2023%
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal
By Alan, on May 20th, 2023%
Both the total investment dollars and number of venture deals in Q1 2023 are the lowest single quarter totals since 2019. . . . → Read More: Infographic – U-Turn on A.I. Venture Funds in Q1
By Alan, on May 18th, 2023%
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round. . . . → Read More: Brain-Computer Device Company Gains $33M in Early Funds
By Alan, on May 13th, 2023%
Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates. . . . → Read More: Infographic – Climate Start-Ups Still Gaining Venture Funds
By Alan, on May 11th, 2023%
A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications. . . . → Read More: Quantum Technology Start-Up Accelerator Unveiled
By Alan, on May 8th, 2023%
Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses
By Alan, on May 6th, 2023%
Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million. . . . → Read More: Infographic – Psychedelics Funding Coming Down
By Alan, on May 1st, 2023%
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round. . . . → Read More: Biotech to Design Disease-Blocking Drugs, Gains $75M
By Alan, on April 25th, 2023%
A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|